AIM ImmunoTech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.About AIM
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.
CEOThomas Kenwood Equels
CEOThomas Kenwood Equels
Employees23
Employees23
HeadquartersOcala, Florida
HeadquartersOcala, Florida
Founded1966
Founded1966
Employees23
Employees23
AIM Key Statistics
Market cap3.77M
Market cap3.77M
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume62.98K
Average volume62.98K
High today$1.40
High today$1.40
Low today$1.30
Low today$1.30
Open price$1.40
Open price$1.40
Volume56.15K
Volume56.15K
52 Week high$36.00
52 Week high$36.00
52 Week low$1.26
52 Week low$1.26
Stock Snapshot
The current AIM ImmunoTech(AIM) stock price is $1.32, with a market capitalization of 3.77M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.
As of 2025-12-15, AIM ImmunoTech(AIM) stock has fluctuated between $1.30 and $1.40. The current price stands at $1.32, placing the stock +1.5% above today's low and -5.7% off the high.
AIM ImmunoTech(AIM) shares are trading with a volume of 56.15K, against a daily average of 62.98K.
In the last year, AIM ImmunoTech(AIM) shares hit a 52-week high of $36.00 and a 52-week low of $1.26.
In the last year, AIM ImmunoTech(AIM) shares hit a 52-week high of $36.00 and a 52-week low of $1.26.
People also own
Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.